The Pacalis team is a blend of industry and academic expertise, led by co-founder and Monash university alumnus Dr David Bibby as Chief Executive Officer, and co-founder Professor Chris Langmead, ...

New Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

A study reveals distinct brain circuits that psychedelics activate to reduce anxiety without causing hallucinations in mice.

The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); atai expects to ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

Psilocybin has been found to have a profound impact on the brain. When consumed, it interacts with serotonin receptors in the brain, particularly the 5-HT2A receptors. These interactions lead to ...

These compounds are designed to be more stable and easier to dose than traditional psilocybin. By modifying the chemical ...

These compounds retain the therapeutic benefits of psilocybin while addressing its limitations related to stability and dosing. These novel derivatives act as serotonin receptor agonists, targeting ...

SSDP describes the two compounds as "essential research chemicals in pre-clinical psychiatry and neurobiology," noting that ...

It says DOI, in particular, has been "a cornerstone in neuroscience research" due to its selectivity for the 5-HT2A serotonin receptor, crucial for understanding the therapeutic effects of ...